Serum lipid levels vary considerably within individuals over short periods of time due to intrinsic factors, such as hormonal variation 1 and illness, 2 extrinsic factors such as diet, [3] [4] [5] and analytical and quality control factors. 6-8 However, little is known about the relative degree to which behavioural, biological, and genetic traits independently contribute to the within-person variation in serum cholesterol. Understanding the subject and study design characteristics that influence within-person variation in blood lipids has implications for the design of clinical trials examining, for example, dietary and drug interventions. Controlling the degree to which cholesterol fluctuations within individuals could increase the precision of its measurement and decrease the sample size needed to detect a particular effect size.
A secondary purpose was to describe associations between 11 genetic polymorphisms involved in lipid metabolism [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] and within-person variation in total cholesterol and HDL cholesterol. Finally, the authors sought to evaluate the potential importance of these predictors by quantifying the effect of within-person serum cholesterol variation on the sample size needed to detect a given intervention effect.
Methods
Dietary feeding and supplement experiments designed to change serum cholesterol 20, 21 were pooled for this investigation. The database used for these analyses contained information on measurements of total cholesterol and HDL cholesterol performed serially 1-11 days apart on investigatorcontrolled or self-selected diets, information on various genetic polymorphisms, sex, body mass index (BMI = kg/m 2 ), age, smoking (non-smoker versus ever-smoker), and phlebotomy (standardized versus routine).
Three studies, conducted in 1985 and 1986, were observed to have unusually high within-person variance. The within-person standard deviations of total cholesterol for these studies were 0.27, 0.29, and 0.39 mmol/l, two to three times larger than that of the other studies. The authors examined the mean lipid concentrations in these three studies and found an unusually large decrease between the first and the second measurements on the same treatment, compared with almost no difference in mean concentrations between the first and second measurements of the first treatment for all other studies pooled. The extreme difference in these three trials appeared to be due to unusually long periods between the two blood draws, when in fact much of the change in concentration was likely due to the dietary treatment rather than to biological variation. None of these three studies had multiple samples taken under the same conditions in subjects stabilized on their diets. The authors therefore excluded these three studies from analysis. Whereas the original pooled sample size comprised 585 individuals, after exclusions the present analyses included 458 individuals. Some 249 subjects participated in one trial, 132 in two trials, 63 in three trials, and 14 in four or more trials.
Specimen collection and analysis
For all studies, blood was collected after an overnight fast, serum was stored at Ϫ80°C, and total cholesterol and HDL cholesterol were determined with strict laboratory standardization as previously described. [22] [23] [24] Technical coefficients of variation for these assays were within the necessary requirements of the Centers for Disease Control and Prevention standardization programme. In some, but not all studies, phlebotomy technique was standardized by controlling posture of the subject before (standing) and during (either sitting or lying) the blood draw and having the same technicians draw blood from the same anatomical location at the same time of the same days of the week. Genetic polymorphisms were determined in DNA isolated from blood or mouth swabs using polymerase chain reaction (PCR) and restriction enzymes. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Triglycerides or low density lipoprotein (LDL) cholesterol were not included in these analyses because triglycerides were only available on a subset of individuals (n = 342) and LDL lipoprotein cholesterol was calculated 25 in these same subjects rather than directly measured.
Statistical methods
For each person, two or more serum lipid values were measured within each of two or more treatment arms within one or more studies. Analyses were in two steps: estimation of within-person variance and estimation of correlates of within-person variance. Within-person variance was estimated by half the squared difference between each follow-up measure and the first measure of an experimental arm. The interval (in days) was noted as a covariate, as we expected the variance to increase with increasing interval. Each of these estimates (correlated within arm) was theoretically distributed approximately as a 2 based on 1 d.f. A person contributed multiple estimates of variability from each study (in most cases one from each of two diet arms) in which he or she participated.
Correlates of within-person lipid variance were studied in a subsequent set of repeated measures regressions. In this case, the dependent variable was the natural logarithm of the withinperson lipid variance of the given person, repeated over arms and studies. The independent variables included sex, age, 11 genetic polymorphisms, smoking (which rarely changed between studies), BMI, free-living total cholesterol, free-living HDL cholesterol, dietary control, phlebotomy standardization, and blood collection interval. For the genetic analyses there were a few instances of very small sample sizes resulting in uninterpretable results. Therefore, the less-frequently occurring homozygous and heterozygous individuals were grouped. This grouping did not appear to affect the results.
Exponentiation of the category-specific predicted natural logarithm of the within-person lipid variance yields an estimate of the geometric mean of the within-person variance itself. Like any log-normal variable, the geometric mean of the withinperson lipid variance is about two-thirds of the mean of possible estimates of the within-person lipid variance; the estimated within-person standard deviation is about 82% of its mean.
Because many of the within-person variances are estimated from studies with only two diet treatment arms, each with two replications of serum lipid measurements, within-person variances per study are generally imprecisely measured, having two estimates based on 1 d.f. This investigation has little power to address whether within-person variance changes across studies. Although imprecision in the dependent variable does not bias regression coefficients, it does reduce precision of estimation, leading to higher P-values. Two approaches to address this limitation were used. First, the magnitude of the regression estimate was given more importance than the respective P-values (P-values were used descriptively). Second, analyses were repeated in the subgroup of participants who had more precisely defined estimates of within-person variance, because they participated in more than one study, or in studies in which more replicate serum lipid measurements were made. Findings were similar to those presented below (data not shown).
Another methodological point arises because the withinperson variance in cholesterol increases with the passage of time from the date of the initial reference measurement. 26 Intervals between measures in an arm ranged from 1 through 11 days. Preliminary regressions showed the log-variance tending to stabilize for intervals between 5 and 11 days (perhaps in part because there were few measurements at 5, 10, or 11 days), so we recoded all such intervals as 7 days. All regressions included the interval in days as a covariate.
We considered an alternative strategy for estimating variance components in a single step, namely, from mixed models with change in lipid concentration from the first measure in a given study arm as the dependent variable. We did not pursue this strategy as a solution to identifying within-person variance attributable to a particular predictor, because it is not possible in this method to assign a specific amount of within-person variance to a given stratum (e.g. male gender).
The primary analyses focused on within-person variance, because variances are additive across independent variables. However, it is more easily interpretable to express findings about within-person variation on the scale of measurement (i.e. standard deviation). Therefore, within-person standard deviation was computed as the square root of the geometric mean of the variance estimate and 95% CI per level of independent variables. For continuous variables tertiles were used to compute regression-adjusted least squares means.
Results
The 458 individuals who participated in 27 studies are described in Table 1 . The median age was 23 years. Participants were generally lean and about half were women (50.2%). Smoking prevalence was 19%. The mean concentration of total cholesterol was 5.0 mmol/l and that of HDL cholesterol was 1.4 mmol/l. The geometric mean of the within-person standard deviation of total cholesterol was 0.13 mmol/l and of HDL cholesterol 0.04 mmol/l, averaged across studies. Coefficients of variation approximated from these data were 3.0% for total cholesterol and for HDL cholesterol.
The repeated measures regression analyses describing predictors of the within-person variance (log-transformed) in total cholesterol and HDL cholesterol are presented in Table 2 . Geometric means of within-person standard deviations in total and HDL cholesterol are shown according to levels of the predictor variables. The interval between replicate blood draws was a significant predictor of the within-person variation of both total (P Ͻ 0.001) and HDL cholesterol (P Ͻ 0.001) after adjustment for all other factors. For total cholesterol, the standard deviation increased from 0.097 mmol/l for 1-day intervals to 0.136 for 7-day intervals. For HDL cholesterol the within-person standard deviation was 0.034 mmol for 1-day intervals and 0.045 mmol/l for intervals of 7 days. For both total cholesterol and HDL cholesterol, a higher within-person variation (P Ͻ 0.01) was observed during treatments without dietary control in comparison to controlled feeding treatments. Phlebotomy standardization appeared to decrease the withinperson variation of total cholesterol (P Ͻ 0.01) but not HDL cholesterol. Other predictors of within-person variation were gender (women more variable for total cholesterol only, P Ͻ 0.02), and average cholesterol concentration (for HDL cholesterol only, P Ͻ 0.01). The findings were similar when stratified by individuals who participated in one study versus those who participated in more than one study (data not shown). Table 3 includes the analyses of the within-person variance in total and HDL cholesterol for 11 genetic polymorphisms. Each polymorphism was examined in an independent regression model with adjustment for the respective lipid concentration and further adjustment for all other factors as previously described. Although statistical power was lacking due to some small sample sizes for specific polymorphisms, apolipoprotein A4 Ϫ347 (0.015 mmol/l higher for genotype 12/22 versus genotype 11, P = 0.02), and microsomal triglyceride transfer protein Ϫ493 (0.017 mmol/l higher for genotype 11 versus genotype 12/22, P = 0.004) appeared to demonstrate associations with within-person variation in total cholesterol after adjustment for all other factors.
Within-person variance estimates were used to estimate the independent impact of sex, phlebotomy technique, and dietary control on the sample size needed to detect a given effect size in the cholesterol concentration. The results are presented in Table 4 . For total cholesterol, a study using self-selected diets (c.f. controlled diets) would require approximately 77% more subjects (e.g. 36 versus 20 subjects). A study using unstandardized phlebotomy (c.f. standardized phlebotomy) would require approximately 57% more subjects (e.g. 32 versus 20 subjects). A study of women in comparison to a study of men would require approximately 31% more subjects (e.g. 26 versus 20 subjects). For HDL cholesterol the only factor among these four that predicted with-person variation was self-selected (c.f. controlled) diet, estimated to increase the sample size needed to detect an intervention effect by 39% (e.g. 28 versus 20 subjects).
Discussion
The approximate median within-person standard deviation from the pooled data was 0.13 mmol/l for total cholesterol and 0.04 mmol/l for HDL cholesterol. The estimated coefficients of variation were 3.0% both for total serum cholesterol and for HDL cholesterol. These estimates are relatively low in comparison to other studies and with respect to requirements of quality control. 3, 7, 27 Jacobs et al. 3 studied serum cholesterol in 58 men who participated in six feeding experiments in the early 1960s. The mean within-person variation in total cholesterol reported by Jacobs et al., 3 after multiplying by 0.66 for a more appropriate comparison to the geometric means of the present study, was 0.460 mmol/l with a range across individuals of 0.155 to 1.161 mmol/l. The within-person variation in the study of Jacobs et al. 3 was computed across diet periods holding Keys' Score constant; therefore, the within-person variance pertains to periods of 3-10 weeks. In comparison, the present study computed within-person variation over 1-7 days within dietary treatment arms, then averaged across all treatment arms in which the participants were observed. Since Rotterdam and colleagues 26 have found that within-person variation increases with time between measurements (a finding confirmed by the present study), this may have resulted in the lower variation of the present study in comparison to that estimated by Jacobs et al. 3 Another factor in the low within-person standard deviations presented here is that the geometric mean estimates are about 18% smaller than estimates which would be obtained directly from sum of squared deviations in a particular subgroup. The difference between the present study and that of Jacobs et al. 3 may be further explained by better phlebotomy and laboratory standardization in the more recent studies. Phlebotomy standardization was an important predictor of within-person variation. Simultaneous repeated measures regression analysis including all independent variables. Blood collection interval was not adjusted for phlebotomy standardization or dietary control (and vice versa) as these variables were very highly correlated. To express total cholesterol and HDL cholesterol in mg/dl multiply by 38.6666. Separate models for each polymorphism included serum cholesterol concentration, blood draw interval, diet control, age, sex, body mass index, and smoking. To express total cholesterol and high density lipoprotein cholesterol in mg/dl multiply by 38.6666. c There are two mutations that cause this polymorphism. The biological mechanism behind within-person variation in cholesterol levels lies in intrinsic factors related to liver synthesis and tissue utilization, as regulated by genetic factors and their interactions with extrinsic factors. With regard to intrinsic factors, the hypothesis, based on previous findings, 1 that women would have higher levels of within-person variation for total cholesterol was supported. This higher within-person variation in women likely reflects menstrual cycling. However, this hypothesis was not supported for HDL cholesterol. This higher level of variation, along with the smaller effects of dietary interventions on lipid levels in women in comparison to men, has been recently described from these same studies 20 and may necessitate larger sample sizes for study of cholesterol interventions in women. Any effect of BMI and age on cholesterol variation may have been accounted for by adjustment for the free-living total cholesterol concentration. It is also quite possible that age and BMI are more important predictors of within-person variation in cholesterol in older and fatter populations.
Identification of genes that affect within-person variation in cholesterol independent of concentration may be important for improving the accuracy of screening, especially if these genes may also increase the risk for dyslipidaemia and coronary disease. In individuals with such mutations, effects of interventions and prediction of CHD risk based on one or two lipid measurements may be obscured by within-person variation. Although analyses of genetic polymorphisms were exploratory, two polymorphisms appeared to be associated with withinperson variation in total (apolipoprotein A4 Ϫ347 and microsomal triglyceride transfer protein Ϫ493) cholesterol. In one other study of men with peripheral arterial disease, those heterogeneous for the apolipoprotein B EcoRI polymorphism had higher within-individual variation of total serum cholesterol concentration. 28 In contrast, in the present study a non-significant trend towards higher within-person variance for those who were homozygous for apolipoprotein B EcoRI was observed. However, these findings are tenuous due to small effect sizes, multiple comparisons, and the small sample sizes for some of the genotype subgroups.
One limitation of the present study is that there are many other extrinsic factors that are known to affect lipid concentration and that may therefore affect within-person lipid variation. These factors include physical activity level (through effects on synthesis and utilization and/or body composition), alcohol consumption, psychological stress, and acute illness. 27 It is important to note that these factors did not appear to vary considerably in the trials included in the present analyses. Another limitation is the relative homogeneity of the population in terms of race, age, and BMI. Within-person variation is likely to vary within and among populations due to varying genetic and environmental factors. The conclusions drawn herein may therefore not necessarily apply to the planning of cholesterol interventions in other settings. Also, the individuals enrolled in these trials were free of chronic disease and did not have elevated serum lipid levels. Quantification of within-person variation in lipids, and the predictors of such in populations with elevated lipid concentrations or advanced atherosclerosis is desirable and may be particularly important for accurately assessing secondary prevention efforts.
These findings may have particular implications for the design of intervention studies when the outcome is serum cholesterol concentration. Given the estimation of within-person variability and the factors that predict this variability, the necessary sample size to detect important effects on serum cholesterol appears to be dependent on certain characteristics of the study design and the subjects who are recruited. One important issue concerns decreasing the days between replicate blood draws, which would decrease the within-person variation. However, as illustrated in Figure 1 , this strategy cannot be recommended Figure 1 Daily variation in serum total cholesterol concentration (oscillating solid line) for a hypothetical subject switching from a high to a low saturated fat diet. The dashed straight horizontal line represents the true mean cholesterol concentration for the subject, which makes a smooth transition to the lower concentration after the dietary change (day 29). The shape of the variation curve is theoretical, and based on the half life of low density lipoprotein particles in plasma (about 2-3 days). The arrows identify blood samples taken one day apart towards the end of each diet when designing studies as it is likely to result in a biased estimate of the true serum cholesterol concentration, and therefore a poor estimate of the change in serum cholesterol concentration from one treatment to another. As shown in Figure 1 , the two measurements that are one day apart during each diet would demonstrate excellent precision but would underestimate true biological variability over time for this hypothetical individual (i.e. poor accuracy). The average cholesterol concentration from the two measurements is a poor estimate of the individuals' true mean during each dietary period. The response to the low saturated fat intervention will vary widely depending on whether the two consecutive measurements are taken during a peak or a trough in the periodicity of serum cholesterol. In this case, the true intervention effect for the individual would be Ϫ0.45 mmol/l (95% CI: 5.10, 4.65 mmol/l), but the observed effect would be Ϫ0.85 mmol/l (95% CI: 5.25, 4.40 mmol/l), an 89% overestimation. When each treatment lasts several weeks or more (as is usually the case), changes in cholesterol from one treatment to another are estimated more precisely and the chance of obtaining a significant intervention effect is optimized by taking multiple measurements on each treatment several days apart under controlled laboratory and experimental conditions. The withinperson variance of total cholesterol, and therefore the sample size needed to detect a given effect size in trials with cross-over designs, may be considerably affected by the sex of the subjects and whether diet is controlled and phlebotomy is standardized. These findings may have important implications for the time and cost of such interventions.
